Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
0Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Celcuity Inc. (CELC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
6Total relationships
2Distinct source URLs
6High confidence
0.907Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from PFE graph: Reciprocal relationship from CELC graph: The Company entered into a license agreement with Pfizer to research, develop, manufacture and commercialize gedatolisib.
Celcuity Inc. Customers
No clients on recordCelcuity Inc. does not appear to disclose named customer relationships in its verified regulatory filings. Many companies do not publicly name customers in regulatory disclosures.
Celcuity Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
CELC-DEBT-8579
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
CELC-DEBT
Debt stack $5,830
90%
Market cache reports total debt of $5,830.
CELC-DEBT-8578
Warrants outstanding: 1827357
90%
xbrl warrant detail from xbrl 2025-12-31.
Celcuity Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Celcuity Inc..
Celcuity Inc. Ownership
Holder
Name
Confidence
Evidence
CELC-OWNER-BAKER-BROS-ADVISORS-LP
BAKER BROS. ADVISORS LP
90%
13F overlay lists BAKER BROS. ADVISORS LP as top holder; 281 tracked holders.
